4-[6-(5---2-)-2---4-]--1-嶡 Ӣ tert-butyl 4-[6-[(5-formyl-1,3-thiazol-2-yl)amino]-2-methylpyrimidin-4-yl]piperazine-1-carboxylate ʽ C18H24N6O3S 404.48700 |(zh) 404.16300 PSA 128.79000
؛̖(ho) | Ҏ(gu) | (sh) | r(ji) |
---|---|---|---|
Q-0106491 | 100mg |
1
|
ԃr(ji) |
Q-0106491 | 250mg |
1
|
ԃr(ji) |
Q-0106491 | 500mg |
1
|
ԃr(ji) |
Q-0106491 | 1g |
1
|
ԃr(ji) |
Q-0106491 | 5g |
1
|
ԃr(ji) |

4-[6-(5---2-)-2---4-]--1-嶡
Ӣ tert-butyl 4-[6-[(5-formyl-1,3-thiazol-2-yl)amino]-2-methylpyrimidin-4-yl]piperazine-1-carboxylate
ʽ C18H24N6O3S
404.48700
|(zh) 404.16300
PSA 128.79000
LogP 2.93060
P(gun)a(chn)Ʒ
(S)-2--3-((S)-2--3-)}} CAS:2628280-48-6
(R)-ʰ嶡}} CAS:256478-95-2
3,4--2-(()) CAS:2136287-65-3
N-(5,6-һ-2,3--1H--2-)-2,2,2- CAS:601487-87-0
N-̪-DL-Ȱ CAS:3343-28-0
4--3--2- CAS:170621-86-0
ʲ@ CAS:53956-04-1
B(ti)w/ĩ/Һ
a(chn)أ
(ch)r(sh)g1
棺
;
SңpgӹٷƼ˾

(sh)Ϣ | |
---|---|
^B(ti) | wĩ |
|(zh)ָ(bio) | 95%+ |
ܽl | ЙC(j)܄/ˮ |
CAS̖(ho) | N/A |
N/A | |
(ch)l | -20ܹⱣ |
(ch)r(sh)g | 1 |
\(yn)ݔl | Ҝ2 |
a(chn)Sң | pgӹٷƼ˾ |
-
pgӹٷƼ˾ṩ Danoprevir;ITMN-191; R7227; RO5190591; RG7227CAS850876-88-9 ^N/A N/A Hʹ
-
pgӹٷƼ˾ṩ DalfopristinCAS112362-50-2 ^N/A N/A Hʹã
-
N-Z-D-B Ӣ (R)-5-AMino-2-(((benzyloxy)carbonyl)aMino)pentanoic acid CAS̖(ho) 112229-51-3 266.293 ܶ 1.20.1 g/cm3
-
2-[3,2-b]-3- Ӣ 2-methylfuro[3,2-b]pyridin-3-ol ʽ C8H7NO2 149.14700 |(zh) 149.04800 PSA 46.26000 LogP 1.84180